31 results
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
of incorporation and failing to adopt the proposed Charter Amendment could impact our recruitment and retention of exceptional officer candidates that conclude … , consistent with current market practice and our retention objectives
Minimize Inappropriate Risk Taking. Our compensation program is weighted toward
8-K
EX-10.1
3isk23l0yd1kp
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
S-1
EX-10.5
hi0xl tbn
21 Dec 18
IPO registration
4:39pm
S-1/A
EX-10.5
prvb5fm0 4qaq90ro
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
EX-10.6
xm1dp95vry0 gwyzk
23 Jan 19
IPO registration (amended)
4:39pm
S-1
EX-10.6
h5q1fd0mdt4x5
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.15
ut4oxbun 4yi0
21 Dec 18
IPO registration
4:39pm
DRS
EX-10.11
c92mfnv8u7 ygd
11 Oct 18
Draft registration statement
12:00am
8-K
EX-4.1
3ssx6
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
S-3ASR
EX-4.4
zn7mtz
3 Mar 22
Automatic shelf registration
4:05pm
S-3ASR
EX-4.4
z10 pfygdpudk
10 Apr 20
Automatic shelf registration
4:33pm
DRS
EX-10.13
usn3xgc5gsbcp8
11 Oct 18
Draft registration statement
12:00am
S-1
EX-10.17
ywkoauntz536ef
21 Dec 18
IPO registration
4:39pm